Secretory Leukocyte Peptidase Inhibitor
"Secretory Leukocyte Peptidase Inhibitor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A proteinase inhibitor found in various BODILY SECRETIONS that coat mucosal surfaces such as SEMINAL PLASMA; CERVICAL MUCUS; and bronchial secretions. It plays a role in protecting epithelial tissues from LEUKOCYTE-derived serine proteases such as NEUTROPHIL ELASTASE.
Descriptor ID |
D053481
|
MeSH Number(s) |
D12.644.822.500 D12.776.645.500
|
Concept/Terms |
Secretory Leukocyte Peptidase Inhibitor- Secretory Leukocyte Peptidase Inhibitor
- Antileukoprotease
- Bronchial Mucus Elastase Inhibitor
- Seminal Proteinase Inhibitor
- Mucus Protease Inhibitor
- Protease Inhibitor, Mucus
- Mucus Proteinase Inhibitor
- Proteinase Inhibitor, Mucus
- Secretory Leukocyte-Protease Inhibitor
- Secretory Leukocyte Protease Inhibitor
- Secretory Leukoprotease Inhibitor
- Leukocyte Peptidase Inhibitor, Secretory
- Elastase Inhibitor, Mucus
- Mucus Elastase Inhibitor
|
Below are MeSH descriptors whose meaning is more general than "Secretory Leukocyte Peptidase Inhibitor".
Below are MeSH descriptors whose meaning is more specific than "Secretory Leukocyte Peptidase Inhibitor".
This graph shows the total number of publications written about "Secretory Leukocyte Peptidase Inhibitor" by people in this website by year, and whether "Secretory Leukocyte Peptidase Inhibitor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Secretory Leukocyte Peptidase Inhibitor" by people in Profiles.
-
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol. 2007 Sep; 14(9):1102-7.